Követés
Ferenc Dr. Sztanek
Ferenc Dr. Sztanek
Ismeretlen szervezet
E-mail megerősítve itt: belklinika.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
The human paraoxonase‐1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters
HZ Mirdamadi, F Sztanek, Z Derdak, I Seres, M Harangi, G Paragh
British journal of clinical pharmacology 66 (3), 366-374, 2008
832008
Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease
F Sztanek, I Seres, M Harangi, L Lőcsey, J Padra, GJR Paragh, L Asztalos, ...
Nephrology Dialysis Transplantation 27 (7), 2866-2872, 2012
552012
Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity
M Harangi, HZ Mirdamadi, I Seres, F Sztanek, M Molnár, A Kassai, ...
Translational Research 153 (4), 190-198, 2009
532009
Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels
I Seres, L Bajnok, M Harangi, F Sztanek, P Koncsos, G Paragh
Paraoxonases in Inflammation, Infection, and Toxicology, 129-142, 2010
482010
Az oxidatív stressz szerepe a diabeteses neuropathia kialakulásában| The role of oxidative stress in the development of diabetic neuropathy
F Sztanek, Á Molnárné Molnár, Z Balogh
Orvosi hetilap 157 (49), 1939-1946, 2016
342016
Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients
E Varga, I Seres, M Harangi, F Sztanek, L Asztalos, L Lõcsey, B Borbás, ...
Disease Markers 26 (3), 141-148, 2009
232009
Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy
B Nádró, H Lőrincz, Á Molnár, A Szentpéteri, E Zöld, I Seres, D Páll, ...
Journal of International Medical Research 49 (5), 03000605211012213, 2021
212021
A diabeteses cardialis autonóm neuropathia diagnosztikája= Diagnosis of diabetic cardiac autonomic neuropathy
F Sztanek, É Jebelovszki, B Gaszner, M Zrínyi, D Páll, P Kempler, ...
Orvosi Hetilap 160 (35), 1366-1375, 2019
182019
Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease
F Sztanek, I Seres, M Harangi, L Lőcsey, P Koncsos, G Paragh
Kidney and Blood Pressure Research 36 (1), 310-319, 2013
172013
Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients
L Locsey, I Seres, F Sztanek, M Harangi, J Padra, D Kovacs, R Fedor, ...
Transplantation proceedings 45 (10), 3685-3687, 2013
172013
Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure
É Varga, I Seres, M Harangi, I Kárpáti, P Koncsos, F Sztanek, G Paragh
Kidney and Blood Pressure Research 35 (4), 265-272, 2012
122012
Determination of serum progranulin in patients with untreated familial hypercholesterolemia
B Nádró, H Lőrincz, L Juhász, A Szentpéteri, F Sztanek, É Varga, D Páll, ...
Biomedicines 10 (4), 771, 2022
92022
Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with diabetic neuropathy
F Sztanek, I Seres, H Lorincz, A Molnar, G Paragh
Atherosclerosis 263, e263, 2017
72017
New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists
F Sztanek, LI Tóth, A Pető, M Hernyák, Á Diószegi, M Harangi
Biomedicines 12 (6), 1320, 2024
62024
The effect of α-lipoic acid treatment on plasma asymmetric dimethylarginine, a biomarker of endothelial dysfunction in diabetic neuropathy
F Sztanek, H Lőrincz, Á Molnár, A Szentpéteri, E Zöld, I Seres, D Páll, ...
Archives of Medical Science, 2020
52020
Change of fibroblast growth factor 21 level correlates with the severity of diabetic sensory polyneuropathy after six-week physical activity
Á Molnár, A Szentpéteri, H Lőrincz, I Seres, M Harangi, Z Balogh, ...
Reviews in Cardiovascular Medicine 23 (5), 160, 2022
42022
Gender-dependent associations between Serum Betatrophin levels and Lipoprotein subfractions in diabetic and nondiabetic obese patients
H Lőrincz, S Csiha, B Ratku, S Somodi, F Sztanek, I Seres, G Paragh, ...
International Journal of Molecular Sciences 24 (22), 16504, 2023
32023
Diabetic neuropathy and other diabetic complications at the Diabetic Neuropathy Center of the University of Debrecen
F Sztanek, B Balogh, Á Molnár, E Zöld, N Tóth, AÁ Jakab, G Paragh
Orvosi Hetilap 161 (30), 1243-1251, 2020
32020
A diabeteses neuropathia és az irizin hormon változása fizikai aktivitás hatására 2-es típusú cukorbetegségben.
F Sztanek, V Kiss, Eszter, A Molnár, I Seres, H Lőrincz, G Paragh, ...
Diabetologia Hungarica 24 (3.), 189-197., 2016
32016
Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity
H Lőrincz, S Csiha, B Ratku, S Somodi, F Sztanek, G Paragh, M Harangi
International Journal of Molecular Sciences 25 (11), 6264, 2024
22024
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20